IBD-included ulcerative colitis (UC) and ‘ ‘Crohn’s disease (CD) are characterized by the release of pro-inflammatory cytokines, for example, TNF-α (alpha tumor necrosis factor), causing further damage to the barrier function and perpetuating inflammation [2,3]. This evidence concerns the gene TNF and inflammatory bowel disease.